Turmeric has been food and medicine across South Asia for centuries. Its strongest modern result is for osteoarthritis pain: standardized extracts have matched anti-inflammatory drugs in head-to-head trials.
Adding it to standard treatment also helps induce remission in mild-to-moderate ulcerative colitis, and there are smaller, earlier signals in mood and in markers of inflammation. In Chinese medicine the same root is Jiang Huang, a warm, blood-moving herb long used for painful, obstructed joints.
Findings & Outcomes
What It Is
Turmeric is the golden-orange root of Curcuma longa, a staple of South Asian cooking and of traditional medicine for centuries. Curcumin is the pigment that turns it yellow, and only a few percent of the root by weight. Almost every health claim rests on curcumin, the isolated compound.
The evidence is thinner than the reputation. A few uses rest on solid trials; most of the rest is thin or absent.
Anatomy of the Practice
1The spice and the molecule
Turmeric root is dried and ground into the familiar yellow powder. Curcumin, and its close relatives the curcuminoids, make up only about two to five percent of it. Cooking with turmeric delivers a small amount of curcumin alongside everything else in the whole root; a supplement concentrates it many times over.
2The absorption bottleneck
Swallowed on its own, curcumin is poorly absorbed. The gut wall and liver break it down and clear it so fast that blood levels after a plain dose are barely detectable. Piperine, a compound in black pepper, blocks that breakdown and raised absorption roughly 20-fold in one study of volunteers. That is why serious formulations pair curcumin with piperine or rework it for uptake.
3Where it acts
Curcumin dampens several inflammatory signals, the mechanism behind the joint-pain results. The clinical trials in people are the part that carries weight.
What It Does
Osteoarthritis has the strongest evidence, the most trials, a large head-to-head test against a standard anti-inflammatory drug, and centuries of traditional use. Ulcerative colitis comes next, with fewer trials but a clear effect when curcumin is combined with standard therapy. Mood and markers of inflammation form a third, earlier group, where the studies are small and short.
In 2017 a medicinal-chemistry review classified curcumin as a pan-assay interference compound, a molecule that trips unrelated lab tests without necessarily doing anything. A share of the in-vitro signal behind its fame is an artifact of that interference. The critique lands on the laboratory work. The clinical trials measured outcomes in people and stand on their own.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Pain
Turmeric extract cut osteoarthritis pain about 2 points on a 10-point scale
In pooled trials, turmeric extract cut arthritis pain by about 2 points on a 10-point scale compared with a dummy pill, and worked about as well as standard pain medicines. The trials were small and short.
A systematic review and meta-analysis pooled 8 randomized trials of turmeric extract or curcumin for arthritis, mostly knee osteoarthritis. Three trials showed a reduction in pain on a visual analogue scale versus placebo (mean difference -2.04 points, 95% CI -2.85 to -1.24), and four showed a fall in the WOMAC index (mean difference -15.36, 95% CI -26.9 to -3.77). Across five trials there was no significant difference in pain between turmeric/curcumin and the comparison pain medicine. The effective dose was around 1000 mg of curcumin a day. The 8 trials carried low to moderate risk of bias, and the authors state the total sample size and study quality were not yet enough for a firm conclusion.
The signal is strong enough to try, and the cheapest way in is turmeric in cooking. If you want the trial-level dose you need a standardized extract, since the curcumin in a spice jar is a small fraction of what the studies used. Give any trial a fixed window of 8 to 12 weeks and judge it by your own pain and movement, then keep it or stop.
The study · 1
Daily et al., turmeric extracts and curcumin for joint arthritis: a systematic review and meta-analysis · J Med Food 2016;19(8):717-29
Turmeric matched ibuprofen for knee osteoarthritis over 4 weeks, with fewer stomach complaints
In the largest head-to-head trial, a turmeric extract eased knee arthritis about as well as ibuprofen over four weeks, and caused fewer stomach complaints.
A multicenter randomized trial assigned 367 patients with primary knee osteoarthritis and a pain score of 5 or higher to either turmeric (Curcuma domestica) extract 1500 mg a day or ibuprofen 1200 mg a day for 4 weeks. On a noninferiority test, the turmeric group matched ibuprofen for WOMAC total, pain and function scores; the stiffness subscale showed a trend but did not reach the threshold. Overall adverse events were similar between groups, but abdominal pain and discomfort were significantly more common with ibuprofen. Most patients in both arms were satisfied with treatment.
This is the strongest single comparison, and it points to a usable alternative for someone who does not tolerate anti-inflammatory drugs. It ran only four weeks, so it speaks to short-term relief, not to years of use.
The study · 1
Kuptniratsaikul et al., Curcuma domestica extracts compared with ibuprofen in knee osteoarthritis · Clin Interv Aging 2014;9:451-8
Curcumin 1500 mg a day beat placebo for knee osteoarthritis over 6 weeks
In a small placebo-controlled trial, a curcumin supplement improved knee arthritis pain and function more than a dummy pill over six weeks, and was well tolerated.
A randomized double-blind placebo-controlled pilot gave 40 patients with mild to moderate knee osteoarthritis either curcuminoids 1500 mg a day in three divided doses (n=19) or matched placebo (n=21) for 6 weeks. The curcuminoid group showed significantly greater reductions in the WOMAC index (p=0.001), the visual analogue pain scale (p<0.001) and Lequesne's functional index (p=0.013). Within WOMAC, pain and physical-function subscores improved but stiffness did not. No considerable adverse effects appeared in either group. It is a pilot: 40 people, 6 weeks.
The study · 1
Panahi et al., curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial · Phytother Res 2014;28(11):1625-31
How it works
Curcumin is barely absorbed alone; black pepper raised uptake about 2000%
Swallowed on its own, curcumin barely reaches the bloodstream because the gut and liver clear it fast. A pinch of black pepper (piperine) raised how much got through by roughly twentyfold.
A pharmacokinetic study measured curcumin in the blood of healthy volunteers after a 2 g oral dose. On its own, serum levels were undetectable or very low, because curcumin is rapidly metabolized in the intestinal wall and liver. Co-administering 20 mg of piperine, an inhibitor of that glucuronidation, produced much higher concentrations from 15 minutes to 1 hour after dosing, an increase in bioavailability of about 2000% in humans (and 154% in rats), with no adverse effects at the doses used. This absorption gap is why formulation matters so much: results from cell and animal work using direct exposure do not automatically carry to a person swallowing a capsule.
The study · 1
Shoba et al., influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers · Planta Med 1998;64(4):353-6
A 2017 review flagged curcumin as a pan-assay interference compound
Curcumin sets off laboratory tests whether or not it is doing anything, so a large share of the impressive lab findings behind its reputation may be an artifact of the testing itself.
Curcumin makes up as much as 5% of turmeric and has been investigated in more than 120 clinical trials. A detailed review of its medicinal chemistry classified it as both a PAINS (pan-assay interference compound) and an IMPS (invalid metabolic panacea): it is chemically unstable, reactive, and non-bioavailable, and it interferes with many common assays, generating apparent activity across unrelated targets. The authors report that no double-blind, placebo-controlled clinical trial of curcumin known to them had succeeded, and argue the compound is a highly improbable drug lead. This does not erase the joint-pain trials, which measured clinical outcomes in people and not signals in a dish, but it is the reason a mechanism claim about curcumin deserves more scrutiny than the volume of papers suggests.
The study · 1
Nelson et al., the essential medicinal chemistry of curcumin · J Med Chem 2017;60(5):1620-37
Curcumin lowered C-reactive protein by 6.4 mg/L, only in absorption-enhanced forms
Curcumin supplements lowered a common blood marker of inflammation across six trials, but only when the product was formulated for absorption and taken for a month or more.
A meta-analysis pooled 6 trials (172 people on curcuminoids, 170 on placebo) measuring circulating C-reactive protein. Supplementation lowered CRP by a weighted mean difference of 6.44 mg/L (95% CI -10.77 to -2.11, p=0.004). The effect persisted in the subgroups using bioavailability-improved preparations and supplementing for 4 weeks or longer, and did not hold in the subgroups without those features, which points straight back at the absorption problem. Heterogeneity across trials was high, and the authors call for longer, well-designed studies.
To move an inflammation marker, the formulation matters more than the dose: the pooled effect appeared only with absorption-enhanced products taken for at least a month.
The study · 1
Sahebkar, are curcuminoids effective C-reactive protein-lowering agents in clinical practice: evidence from a meta-analysis · Phytother Res 2014;28(5):633-42
Digestion
Curcumin added to mesalamine roughly doubled ulcerative colitis remission across 8 trials
For mild-to-moderate ulcerative colitis, adding curcumin to standard mesalamine treatment helps more people reach remission. Across 8 trials, about twice as many people went into remission on curcumin plus their usual medicine as on the medicine alone. In one trial, more than half reached remission in four weeks while none did on placebo. The trials are small and their results vary, and curcumin works best taken alongside mesalamine, not in place of it.
Ulcerative colitis is one of curcumin's best-studied uses. A 2025 meta-analysis pooled 8 randomized controlled trials (482 patients) and found that curcumin added to standard therapy roughly doubled the odds of clinical remission compared with placebo (RR 2.33, 95% CI 1.25-4.34) and improved endoscopic improvement (RR 1.76, 95% CI 1.12-2.77). The landmark trial behind this is Lang 2015, a double-blind study of 50 patients with mild-to-moderate disease who continued mesalamine and added either 3 g/day curcumin or placebo for a month: 53.8% on curcumin reached clinical remission against none on placebo, with clinical response of 65.3% versus 12.5%. Two things temper the picture. The trials are small and disagree with one another (I-squared 80%), so the true effect size is hard to pin down, and endoscopic remission on its own did not reach statistical significance in the pooled analysis. The evidence is strongest for curcumin used as an add-on to mesalamine to induce and help maintain remission. Because plain curcumin is absorbed poorly, the formulation and dose matter, and the doses used in these trials come from concentrated extracts, not from food.
Who this may not transfer to:Trials enrolled both men and women with ulcerative colitis; no sex-specific difference in response is established.
The studies · 2
Lang et al., Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial · Clinical Gastroenterology and Hepatology
Mood & stress
Curcumin lowered depression scores across 6 trials in 377 patients
Adding curcumin lowered depression scores across six small trials. The effect was modest, the studies were short, and this is early evidence, not a settled result.
A meta-analysis of 6 clinical trials (377 patients) compared curcumin with placebo for depression. The pooled standardized mean difference in Hamilton Depression Rating Scale scores was -0.344 (95% CI -0.558 to -0.129, p=0.002), a modest reduction, with anti-anxiety effects reported in three of the trials and no adverse events in any of them. The authors flag the limits plainly: few studies, so a funnel plot or sensitivity analysis was not possible, and all trials ran only 4 to 8 weeks, leaving longer-term efficacy and safety open. Most trials were at low risk of bias, with one open and one single-blind exception.
Read this as a possible add-on to treatment a clinician is already managing, not a replacement for it. The trials were short, so it is reasonable to try alongside standard care and review it with whoever oversees that care.
The study · 1
Ng et al., clinical use of curcumin in depression: a meta-analysis · J Am Med Dir Assoc 2017;18(6):503-8
Curcumin worked about as well as fluoxetine in major depression over 6 weeks
In one trial, curcumin worked roughly as well as a standard antidepressant over six weeks, and pairing the two did slightly better, though the study was too small to be sure of the differences.
A randomized six-week trial split 60 patients with major depressive disorder into three equal arms: fluoxetine 20 mg, curcumin 1000 mg, or both. Response rates on the 17-item Hamilton Depression Rating Scale were 64.7% for fluoxetine, 62.5% for curcumin and 77.8% for the combination, and the mean change in score was comparable across arms; none of these differences was statistically significant (p=0.58 and p=0.77). Curcumin was well tolerated. The authors present it as first clinical evidence that curcumin can be used in MDD without concurrent suicidal ideation, not as a demonstration of superiority.
The study · 1
Sanmukhani et al., efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial · Phytother Res 2014;28(4):579-85
Cholesterol And Lipids
Curcumin modestly lowered LDL cholesterol and triglycerides across 7 trials
In people with cardiovascular risk factors, turmeric and curcumin nudged LDL cholesterol and triglycerides down by a small amount across seven trials.
A meta-analysis of 7 randomized trials (649 patients with cardiovascular risk factors) assessed turmeric and curcumin on blood lipids. Pooled standardized mean differences were -0.340 for LDL cholesterol (95% CI -0.530 to -0.150, p<0.0001) and -0.214 for triglycerides. These are small effect sizes, the trials were heterogeneous in preparation and dose, and the clinical meaning of a shift this size is uncertain in people already managing cardiovascular risk by other means.
The study · 1
Qin et al., turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis · Nutr J 2017;16(1):68
Immune Function
Curcumin with piperine improved inflammation and oxidative-stress markers in metabolic syndrome over 8 weeks
In people with metabolic syndrome, a curcumin supplement paired with black-pepper extract improved markers of inflammation and oxidative stress over eight weeks.
A randomized double-blind placebo-controlled trial gave 117 people with metabolic syndrome either curcuminoids 1 g a day co-supplemented with piperine 10 mg (to raise absorption) or placebo for 8 weeks. The curcuminoid arm showed higher serum superoxide dismutase activity and lower malondialdehyde and C-reactive protein. The trial pairs a marker-level result with a deliberate use of piperine, which is the recurring move needed to make oral curcumin measurable at all.
The study · 1
Panahi et al., antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis · Clin Nutr 2015;34(6):1101-8
How It Works
The working mechanism is anti-inflammatory: curcumin damps inflammatory signaling. In an osteoarthritic joint, less of that signaling plausibly means less pain. Trials used a standardized extract of about 1,000–1,500 mg a day.
Getting It Right
Ways to Do It
Cooking with turmeric is the natural starting point. For the doses the trials used, that means a formulated extract built for absorption.
Turmeric in cooking is a low-cost, low-risk habit. Adding black pepper and a little fat both raise how much curcumin you absorb. Even so, this delivers only a modest amount of curcumin as part of the whole root, well short of a trial dose, so it carries almost no risk.
The osteoarthritis trials used standardized extracts of about 1000 to 1500 mg of curcuminoids daily, not culinary turmeric. Plain curcumin powder barely reaches the blood. Choose a product formulated for uptake: piperine-paired or reworked into a more absorbable form. Look for a third-party testing mark so the capsule holds what the label claims.
Most osteoarthritis trials ran eight to twelve weeks. Give a standardized extract that long, and track your own pain and how the joint moves. At the end, judge whether it helped.
Go Deeper
- Arthritis and joint pain: turmeric's best-supported condition, set beside the movement and load work that helps alongside it.
- Whole foods: a whole-food diet has more evidence than any single supplement, turmeric included.
The Chinese Medicine View
Turmeric is an established herb in the Chinese pharmacopoeia. The dried rhizome of Curcuma longa is Jiang Huang (薑黃). Its taste is acrid and bitter, its nature warm, and it enters the Spleen and Liver channels. Classically it moves the Blood and the Qi, breaks up stasis, and dispels wind-damp painful obstruction, what the tradition calls Bi. It was reached for above all in pain of the shoulders and arms, where cold and damp lodge in the channels and the joints stiffen.
Traditional use and the modern trials point to the same thing: painful joints. The tradition did not measure inflammatory signaling or isolate a molecule. It read a pattern of stagnation and pain, and matched a warm, moving herb to it.
Jiang Huang is the entire rhizome, decocted and combined with other herbs, warmed, and chosen for a particular pattern in a particular person. Curcumin is one purified compound, taken at concentrations no bowl of turmeric would reach.
Centuries of use against obstructed, painful joints is a body of evidence in its own right, tested by more people over more time than any single trial. The classical framing is a lens on the biology, held apart from the trial data.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Single curcumin doses up to 12,000 mg were well tolerated in 24 volunteers
A dose-escalation study gave 24 healthy volunteers single oral doses of a standardized curcuminoid extract from 500 mg up to 12,000 mg to find the maximum tolerated dose. Seven of 24 (30%) experienced only minimal effects that were not dose-related; tolerance was described as excellent. Curcumin was undetectable in serum at doses up to and including 8,000 mg and only faintly present at 10,000 to 12,000 mg, echoing the absorption problem. This speaks to short-term tolerability of a single large dose, not to long-term daily use.Lao et al., dose escalation of a curcuminoid formulation
10 cases of liver injury linked to turmeric supplements, 2004 to 2022
A case series from the US Drug-Induced Liver Injury Network described 10 adjudicated cases of liver injury in which a turmeric supplement was the implicated product, enrolled between 2004 and 2022, with the cases clustering in recent years. The authors tie the growing signal to the popularity of high-dose products formulated for better absorption, some of which also contain piperine that further raises exposure. Injury was hepatocellular in pattern and linked in several cases to a specific HLA type, suggesting an individual susceptibility, not a dose everyone should fear. Against millions of users these events are rare, but they can be serious: in this series one of the ten patients died of acute liver failure and five were hospitalized, though most improve once the supplement is recognized and stopped.Halegoua-DeMarzio et al., liver injury associated with turmeric: ten cases from the Drug-Induced Liver Injury Network
Liver injury from concentrated extracts
Every caution here is about concentrated extracts; turmeric used in cooking raises none of them. Concentrated, absorption-enhanced curcumin supplements, often piperine-paired, have been linked to rare cases of liver injury. If you have a liver condition, check with a clinician first. Stop and seek care if you develop jaundice, dark urine, or abdominal pain while taking one.
Blood-thinning medication
At supplement doses, curcumin can reduce platelet clumping, so it may add to the effect of blood-thinning or antiplatelet drugs such as warfarin, clopidogrel or daily aspirin. If you take one of these, or you have surgery coming up, ask the clinician managing that medication before starting.
Gallbladder and bile ducts
Turmeric stimulates the gallbladder to contract and bile to flow. Usually this is harmless. But with gallstones or a blocked bile duct, that contraction can cause pain, so avoid turmeric supplements until a clinician has checked.
Stomach upset
High doses can bring on nausea, loose stools or stomach discomfort in some people. This usually settles at a lower dose or taken with food. The reassuring tolerability data and the rare adverse reports both come from high-dose extracts.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does turmeric actually help arthritis?
For osteoarthritis, the evidence is reasonably solid. Pooled randomized trials show standardized extracts cut joint pain against placebo. In the largest head-to-head study, an extract matched ibuprofen over four weeks, with fewer stomach complaints. The trials are mostly small and short, so the effect reads as moderate and is not yet settled. It applies to concentrated extracts around 1000 to 1500 mg a day, well above the amount in cooking.
Is turmeric the anti-inflammatory cure-all it is said to be?
No. It is oversold well beyond the two conditions where the trials hold up: osteoarthritis and ulcerative colitis. For everything else, the evidence stays thin.
Can turmeric help with depression?
The evidence here is early and modest, and it points the right way. Pooling six trials in 377 patients, curcumin lowered depression scores against placebo. In a separate trial it did about as well as fluoxetine over six weeks, with the combination slightly better. All these studies were short, four to eight weeks, and small. Curcumin may help as an add-on; discuss it with your clinician. In the trials it was always used alongside standard care.
Can turmeric help ulcerative colitis?
For mild-to-moderate ulcerative colitis, this is one of curcumin's stronger results. Across eight randomized trials in 482 patients, adding curcumin to standard therapy roughly doubled the number reaching clinical remission against placebo. In one trial more than half reached remission in four weeks, while none did on the dummy pill. In the trials the benefit came from curcumin added to mesalamine. They are small and disagree with one another, so the size of the benefit is still uncertain.
Is turmeric safe?
For most people, yes, especially as a cooking spice, and single large doses were well tolerated in a dose-escalation study. The care belongs to concentrated supplements: cooking delivers only a fraction of a 1000-to-1500-mg extract dose. The supplement cautions cover the liver, bleeding, the gallbladder and the stomach.
If you take a daily medication or have a liver, bleeding or gallbladder condition, clear a supplement with a clinician first.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 14 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.